Tag: AMP v. Myriad Genetics
IP Sessions at BIO 2015: The Evolving Landscape of Patentable Subject Matter
The IP Track at BIO 2015 had a number of incredible educational sessions concerning the …
BIO and University Organizations offer Support of STRONG Patents Act
On March 4, 2015, Senator Chris Coons (D-DE) introduced a new bill, The STRONG Patents …
BIO IPCC Spring Conference Program Announced
BIO’s 2015 IP Counsels Committee Spring Conference & Meeting will be held April 15-17 in …
BIO Deputy General Counsel Remarks on Revised Eligibility Guidance
Hans Sauer, BIO’s Deputy General Counsel for Intellectual Property recently spoke at the U.S. Patent …
USPTO Issues New Myriad Guidance
On Tuesday, December 16 the United States Patent and Trademark Office issued a revised guidance …
BIO Submits Joint Supplemental Comments on the USPTO March Guidance
Last week BIO, alongside a number of member companies and private individuals, submitted supplemental comments …
Detailed Report Examines the Crucial Role of Patents in Genetic Testing
In The Critical Role of Patents in the Development, Commercialization, and Utilization of Innovative Genetic …
PTO Patent Examinations in the wake of Mayo and Myriad
Biotech patent applicants are finding themselves in uncharted waters. After the Supreme Court’s decisions …
Debunking the Myth: Your Genes are Patented
MYTH: YOUR GENES ARE PATENTED. FACTS: IT IS NOT POSSIBLE TO PATENT YOUR GENES The …